ACCESSION: MSBNK-SMB_Measured-HSA001P0153005
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 72
COMMENT: RAW_SPEC {'BLK02_6393': {'bp': 197487.0, 'sum': 388557.0}, 'BLK02_6706': {'bp': 195233.0, 'sum': 410844.0}, '15_posi_6816': {'bp': 195170.0, 'sum': 381215.0}, 'BLK02_6452': {'bp': 193464.0, 'sum': 369187.0}, 'BLK02_6879': {'bp': 181967.0, 'sum': 353431.0}, '9_posi_6836': {'bp': 168496.0, 'sum': 340843.0}, 'BLK02_6792': {'bp': 167739.0, 'sum': 354659.0}, 'BLK02_6328': {'bp': 167351.0, 'sum': 348380.0}, 'BLK02_7041': {'bp': 164154.0, 'sum': 314157.0}, '17_posi_6980': {'bp': 161782.0, 'sum': 345507.0}, 'ProcedureBlank_6373': {'bp': 160344.0, 'sum': 317987.0}, 'BLK02_6981': {'bp': 159764.0, 'sum': 329230.0}, 'BLK02_6579': {'bp': 158339.0, 'sum': 334267.0}, 'ProcedureBlank_6729': {'bp': 150267.0, 'sum': 307280.0}, '19_posi_7046': {'bp': 149426.0, 'sum': 303387.0}, '14_posi_6601': {'bp': 148515.0, 'sum': 314902.0}, 'ProcedureBlank_6899': {'bp': 147051.0, 'sum': 298126.0}, '10_posi_6919': {'bp': 146498.0, 'sum': 318472.0}, '11_posi_6982': {'bp': 146302.0, 'sum': 300924.0}, '1_posi_6984': {'bp': 146294.0, 'sum': 281764.0}, '9_posi_6666': {'bp': 144605.0, 'sum': 291491.0}, 'ProcedureBlank_6836': {'bp': 142221.0, 'sum': 296282.0}, '17_posi_6918': {'bp': 141696.0, 'sum': 283684.0}, '13_posi_6836': {'bp': 140556.0, 'sum': 292828.0}, '18_posi_6984': {'bp': 139645.0, 'sum': 318314.0}, '2_posi_6940': {'bp': 138499.0, 'sum': 282711.0}, '1_posi_6731': {'bp': 137286.0, 'sum': 307033.0}, '16_posi_6920': {'bp': 137264.0, 'sum': 289325.0}, '6_posi_6879': {'bp': 136441.0, 'sum': 254061.0}, '17_posi_6857': {'bp': 135268.0, 'sum': 285091.0}, '17_posi_6708': {'bp': 134963.0, 'sum': 268973.0}, 'ProcedureBlank_6435': {'bp': 134791.0, 'sum': 279925.0}, '19_posi_6919': {'bp': 134398.0, 'sum': 275723.0}, '14_posi_6774': {'bp': 132867.0, 'sum': 295535.0}, '8_posi_7045': {'bp': 132779.0, 'sum': 255357.0}, '15_posi_6709': {'bp': 132387.0, 'sum': 271898.0}, '16_posi_6582': {'bp': 132129.0, 'sum': 291853.0}, '10_posi_7047': {'bp': 131818.0, 'sum': 287464.0}, '15_posi_6897': {'bp': 131673.0, 'sum': 269953.0}, '17_posi_7043': {'bp': 131350.0, 'sum': 282259.0}, 'ProcedureBlank_6519': {'bp': 131325.0, 'sum': 271763.0}, '14_posi_7043': {'bp': 131064.0, 'sum': 263703.0}, '13_posi_6939': {'bp': 129938.0, 'sum': 253113.0}, '9_posi_6734': {'bp': 129412.0, 'sum': 279378.0}, '16_posi_6730': {'bp': 129061.0, 'sum': 271408.0}, '19_posi_6478': {'bp': 128924.0, 'sum': 266378.0}, '2_posi_6584': {'bp': 128439.0, 'sum': 255068.0}, '4_posi_6644': {'bp': 127857.0, 'sum': 261796.0}, '16_posi_6814': {'bp': 127855.0, 'sum': 272315.0}, '13_posi_7067': {'bp': 127405.0, 'sum': 285996.0}, '16_posi_6520': {'bp': 126745.0, 'sum': 276929.0}, '5_posi_7066': {'bp': 126587.0, 'sum': 266657.0}, '5_posi_6833': {'bp': 126273.0, 'sum': 273119.0}, '19_posi_6686': {'bp': 126084.0, 'sum': 253541.0}, '8_posi_6433': {'bp': 126028.0, 'sum': 259987.0}, '1_posi_7070': {'bp': 125410.0, 'sum': 262972.0}, '17_posi_6395': {'bp': 125270.0, 'sum': 277825.0}, '7_posi_6732': {'bp': 124233.0, 'sum': 281449.0}, '18_posi_6794': {'bp': 123476.0, 'sum': 263312.0}, '16_posi_6667': {'bp': 123245.0, 'sum': 271309.0}, '18_posi_6606': {'bp': 123219.0, 'sum': 276855.0}, '15_posi_7003': {'bp': 121966.0, 'sum': 252634.0}, '18_posi_6731': {'bp': 121853.0, 'sum': 241306.0}, '18_posi_6857': {'bp': 121043.0, 'sum': 261065.0}, '8_posi_6705': {'bp': 120108.0, 'sum': 249365.0}, '5_posi_6899': {'bp': 119621.0, 'sum': 266840.0}, '2_posi_6479': {'bp': 117164.0, 'sum': 265491.0}, '7_posi_6643': {'bp': 117028.0, 'sum': 263225.0}, '3_posi_6350': {'bp': 115671.0, 'sum': 222979.0}, '15_posi_6562': {'bp': 114435.0, 'sum': 238111.0}, '6_posi_6474': {'bp': 107603.0, 'sum': 238458.0}, '13_posi_6750': {'bp': 105659.0, 'sum': 218647.0}}
COMMENT: RETENTION_TIME_STDEV 0.417
COMMENT: PRECURSOR_M/Z_RAW 153.113098
COMMENT: PRECURSOR_M/Z_STDEV 0.000052
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.224; C7H12N4; [M+H]+; delta(ppm) -0.223528
COMMENT: PROPOSED_MF MS-FINDER 2.656; C7H12N4; [M+H]+; delta(ppm) -0.227572
COMMENT: PROPOSED_MF SIRIUS5_Sirius 13.782; C7H12N4; [M+H]+; delta(ppm) -0.227572
COMMENT: PROPOSED_MF SIRIUS5_Sirius 1.279; C9H14NO; [M+H]+; delta(ppm) -8.996568
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.227572
COMMENT: PROPOSED_MF SIRIUS6_Sirius 26.330; C7H12N4; [M+H]+; delta(ppm) -0.227572
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.661; C4H13FN4O; [M+H]+; delta(ppm) -7.690306
COMMENT: PROPOSED_MF SIRIUS6_Sirius 8.551; C9H14NO; [M+H]+; delta(ppm) -8.996568
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.184; C3H15N5P; [M+H]+; delta(ppm) -2.246352
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C7H12N4; [M+H]+; delta(ppm) -0.227572
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.011; KYAGGLONXREQED-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.872; RWSWNQOCJVPCMF-UHFFFAOYSA-N; [M+H]+; 5-methyl-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.593; RMTCWOLYVMOKBR-UHFFFAOYSA-N; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.573; SAYXVILDUZLWGX-UHFFFAOYSA-N; [M+H]+; 4-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.355; FHYDQGOVTLQZSZ-UHFFFAOYSA-N; [M+H]+; N'-pyrimidin-2-ylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.246; MHMOUFDAKNJXSK-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.229; KFJYLCFNRATSPE-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.146; ASGQRNXDYZQNPS-UHFFFAOYSA-N; [M+H]+; 4-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.000; DAAKLDCBWHWWNI-RMKNXTFCSA-N; [M+H]+; N-methyl-N-[(E)-(1-methylimidazol-2-yl)methylideneamino]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.963; OQHDZWPNEOFLCW-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.950; QDEKQIPSPLAOPI-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.938; YPPVPNFMCXRUCC-UHFFFAOYSA-N; [M+H]+; 4-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.926; SANLPMMCLNQJPP-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.911; GMVWRTAXMQPIBG-UHFFFAOYSA-N; [M+H]+; 5-(1-aminoethyl)-4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.906; QFOSWZIUPHQBRK-UHFFFAOYSA-N; [M+H]+; 8-methyl-2,3,6,7-tetrahydroimidazo[1,2-a]pyrimidin-5-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.895; FILWPDPGRBPZDL-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.872; IMQGJTWGILNPMZ-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a][1,4]diazepin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.860; MSQSNZKVWZTSDJ-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyl-1,2,4-triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.854; JUYYERAJUGNAKT-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1,2,4-triazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.853; JBICIOACIKMMJM-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-N,N-dimethylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.848; GFUMZGPBCAJZHH-UHFFFAOYSA-N; [M+H]+; 2-(4-cyclopropyltriazol-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.846; KHDBXRADZIIFBK-UHFFFAOYSA-N; [M+H]+; 2-(1-cyclopropyltriazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.843; GESFEOZCDXMGFO-UHFFFAOYSA-N; [M+H]+; 2-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.821; DLVUEWDMHXYYAO-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1H-1,2,4-triazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.814; KLDLJJRSWZYEFL-UHFFFAOYSA-N; [M+H]+; 6,6-dimethyl-4,5-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.797; WJXSFSALUZCCJQ-UHFFFAOYSA-N; [M+H]+; 3,8-dimethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.780; LGIWBPLJDKOQSX-UHFFFAOYSA-N; [M+H]+; 4-(2H-triazol-4-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.779; IFPQNVUJBNWAGL-UHFFFAOYSA-N; [M+H]+; 2-methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.778; QCAHQEGOYONBHI-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.774; KGXBEJFERUBKKY-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.773; ZEFRABOWIHXNKA-UHFFFAOYSA-N; [M+H]+; 3-methyl-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-d][1,4]diazepine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.762; XNHWFJRPVBJRPR-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.757; OIZMGVQEOVIMOL-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-pyrrolidin-3-yl-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.757; PWQFWTMOGJDMLO-UHFFFAOYSA-N; [M+H]+; [3-(1,2,4-triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.756; KGLMRCGIKAKFCH-UHFFFAOYSA-N; [M+H]+; 3-(triazol-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.755; MJIWVLBPVFCYJB-ZETCQYMHSA-N; [M+H]+; 1-[[(2S)-pyrrolidin-2-yl]methyl]triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.753; BXSGLNRNBMUCIM-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.749; NMHSRADHFBXGAG-UHFFFAOYSA-N; [M+H]+; 6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.748; FNMXKIOFMCGDMH-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-2-methyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.746; AGIXGQFDUZRXCT-UHFFFAOYSA-N; [M+H]+; 1-(pyrrolidin-2-ylmethyl)-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.745; NNTDOOSCXNZOBK-UHFFFAOYSA-N; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.745; KNGLSUWCXOCEKZ-UHFFFAOYSA-N; [M+H]+; 3-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.743; XDUNSNMMXUKPIN-ZCFIWIBFSA-N; [M+H]+; 4-methyl-3-[(2R)-pyrrolidin-2-yl]-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.739; KELKBKXPSNKQRJ-UHFFFAOYSA-N; [M+H]+; [1-(cyclopropylmethyl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.738; FYKDYYGNYLGWCA-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.737; XMNCTKKZAFGKBV-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-3-yl-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.734; IZHAMQUVVWJULL-UHFFFAOYSA-N; [M+H]+; 3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.733; HSBDIERXOJWHKI-UHFFFAOYSA-N; [M+H]+; 3-(1,2,4-triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.733; URSHNSSBVLGWNY-UHFFFAOYSA-N; [M+H]+; 1-methyl-4,5,6,7-tetrahydrobenzotriazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.731; YRQUFBNVMMTCEX-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.731; UOGYOJNDIFVZLJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.722; GREJTVKJTDGUQI-UHFFFAOYSA-N; [M+H]+; 2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.718; NYWMQSMKGVCQED-LURJTMIESA-N; [M+H]+; 3-methyl-5-[(2S)-pyrrolidin-2-yl]-1H-1,2,4-triazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.712; DKRJNDYSGMPAAB-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.687; COBJBBVQXYDCJU-UHFFFAOYSA-N; [M+H]+; N-[(1-methyltriazol-4-yl)methyl]cyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.679; PWEGFMVXXGYUTH-UHFFFAOYSA-N; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.677; OEURBUBEWIXBKU-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.674; VFXLTLDREFAZCG-UHFFFAOYSA-N; [M+H]+; [3-(triazol-1-yl)cyclobutyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.433; HWXAKUICDBKUDB-UHFFFAOYSA-N; [M+H]+; 4-azidobicyclo[2.2.1]heptan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.763; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -185.189; PWEGFMVXXGYUTH; [M+H]+; 4-N-propan-2-ylpyrimidine-4,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.376; COBJBBVQXYDCJU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -200.837; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.939; DKRJNDYSGMPAAB; [M+H]+; 1,2,4-triazolo[4,5-a]piperidin-3-ylmethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.145; NNTDOOSCXNZOBK; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.093; RMTCWOLYVMOKBR; [M+H]+; 4-N,4-N,6-trimethylpyrimidine-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.530; DKRJNDYSGMPAAB; [M+H]+; (5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-A]pyridin-3-YL)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -142.408; RWSWNQOCJVPCMF; [M+H]+; 5-Methyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.800; COBJBBVQXYDCJU; [M+H]+; N-((1-methyl-1H-1,2,3-triazol-4-yl)methyl)cyclopropanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.843; YRQUFBNVMMTCEX; [M+H]+; 3-methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-8-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -147.909; QDEKQIPSPLAOPI; [M+H]+; 2-(1H-pyrazol-4-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -152.278; XNHWFJRPVBJRPR; [M+H]+; 3-methyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -154.164; YPPVPNFMCXRUCC; [M+H]+; 4-(4H-1,2,4-triazol-3-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -163.741; FYKDYYGNYLGWCA; [M+H]+; (6R)-2-methyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.011; IZHAMQUVVWJULL; [M+H]+; (3R)-3-(1H-1,2,4-triazol-5-yl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -170.906; NNTDOOSCXNZOBK; [M+H]+; 5-cyclopentyl-1H-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.210; DKRJNDYSGMPAAB; [M+H]+; (5,6,7,8-Tetrahydro-[1,2,4]triazolo[4,3-A]pyridin-3-YL)methanamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H13N4; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 13.556
MS$FOCUSED_ION: PRECURSOR_M/Z 153.113438
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-2900000000-9f4f44626168dc7b5423
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0445744 40.7753 69.045200 1.4339 11.55 0.0628 68 f{C3H5N2}/-2.18ppm,p-C4H8N2
  71.0603968 260.6804 71.061010 0.4785 24.32 0.6952 72 f{C3H7N2}/0.31ppm,p-C4H6N2
  83.0601813 86.0613 83.060685 1.1799 14.54 0.6514 72 f{C4H7N2}/-2.33ppm,p-C3H6N2
  85.0758407 78.0520 85.076320 1.4693 15.88 0.3743 72 f{C4H9N2}/-2.16ppm,p-C3H4N2
  110.0713035 157.2807 110.071530 0.9539 20.27 0.5222 72 f{C5H8N3}/0.27ppm,p-C2H5N1
  124.0868849 36.8540 124.086940 1.9422 7.39 0.4105 61 f{C6H10N3}/-0.31ppm,p-C1H3N1
  126.1024032 53.5567 126.102430 1.7922 11.61 0.4431 70 f{C6H12N3}/-1.35ppm,p-C1H1N1
  153.0656742 37.7073 153.065570 2.0383 9.21 0.2379 62 ?
  153.0770842 46.4956 153.076980 2.0317 10.24 0.2755 70 ?
  153.1026442 74.9991 153.102540 1.5414 15.87 0.1673 70 ?
  153.1132442 999.0000 153.113140 0.4702 0.00 1.0000 72 f{C7H13N4}/-1.49ppm,p
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  69.044574 40.78 40
  71.060397 260.68 260
  83.060181 86.06 86
  85.075841 78.05 78
  110.071303 157.28 157
  124.086885 36.85 36
  126.102403 53.56 53
  153.065674 37.71 37
  153.077084 46.50 46
  153.102644 75.00 74
  153.113244 999.00 999
//
